Back
Equity Residential Vs. Rhythm Pharmaceuticals Industry Stock Comparison
Buy
57
EQR
Equity Residential
Last Price:
76.99
Seasonality Move:
0.12%
Buy
73
RYTM
Rhythm Pharmaceuticals
Last Price:
55.28
Seasonality Move:
11.04%
Buy
57
Equity Residential (EQR)
is a Buy
Is Equity Residential a Buy, Sell or Hold?
- The current Equity Residential [EQR] share price is $77.08. The Score for EQR is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.
- EQR is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
73
Rhythm Pharmaceuticals (RYTM)
is a Buy
Is Rhythm Pharmaceuticals a Buy, Sell or Hold?
- The current Rhythm Pharmaceuticals [RYTM] share price is $53.65. The Score for RYTM is 73, which is 46% above its historic median score of 50, and infers lower risk than normal.
- RYTM is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
EQR Stock Price Chart
What is Equity Residential's stock price today?
-
The Equity Residential share price today is $77.08
The current trend is moderately bullish and EQR is experiencing selling pressure, which indicates risk of future bearish movement.
RYTM Stock Price Chart
What is Rhythm Pharmaceuticals's stock price today?
-
The Rhythm Pharmaceuticals share price today is $53.65
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RYTM is experiencing slight selling pressure.
EQR Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 1.62 | Buy |
Relative Strength Index (14 RSI): | 66.22 | Buy |
Chaikin Money Flow: | -1743003 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (72.32 - 76.7) | Buy |
Bollinger Bands (100): | (65.74 - 73) | Buy |
RYTM Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 1.46 | Buy |
Relative Strength Index (14 RSI): | 67.83 | Buy |
Chaikin Money Flow: | -159819 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (45.64 - 50.28) | Buy |
Bollinger Bands (100): | (39.46 - 48.56) | Buy |
EQR Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 77.05 | Buy |
20-day SMA: | 75.26 | Buy |
50-day SMA: | 72.2 | Buy |
200-day SMA: | 65.18 | Buy |
8-day EMA: | 76.9 | Buy |
20-day EMA: | 75.41 | Buy |
50-day EMA: | 72.76 | Buy |
200-day EMA: | 67.06 | Buy |
RYTM Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 50.55 | Buy |
20-day SMA: | 48.38 | Buy |
50-day SMA: | 47.86 | Buy |
200-day SMA: | 43.39 | Buy |
8-day EMA: | 50.8 | Buy |
20-day EMA: | 49.06 | Buy |
50-day EMA: | 47.17 | Buy |
200-day EMA: | 41.51 | Buy |
Equity Residential Earnings Growth & EQR Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.01 per share, an increase next quarter of $0.03 per share, a decrease this year of $0.13 per share, and an increase next year of $0.26 per share.
Rhythm Pharmaceuticals Earnings Growth & RYTM Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.11 per share, an increase next quarter of $0.11 per share, a decrease this year of $1.34 per share, and an increase next year of $1.63 per share.
Equity Residential Technical Analysis
Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Rhythm Pharmaceuticals Technical Analysis
Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |